Guardian Pharmacy Services, Inc. (GRDN) Stock
GRDN has an Alpha Score of 46 out of 100 (weak), computed on Nov 3, 2026 from 3 of 4 sub-scores. 6 of the hedge funds AlphaScala tracks reported GRDN in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Millennium Management's at $5.05M. Its trailing P/E ratio is 39.1 and its net margin 4.5% (key statistics as of Nov 3, 2026).
What is GRDN's Alpha Score?
How it works →Alpha Score of 45 reflects weak overall profile with moderate momentum, poor value, moderate quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Nov 3, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which hedge funds own GRDN?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Millennium Management Israel Englander | 121K | $5.05M | +344% |
| Citadel Ken Griffin | 88K | $3.68M | -85% |
| D.E. Shaw David Shaw | 74K | $3.09M | -2% |
| Renaissance Technologies Jim Simons (founder) | 45K | $1.88M | -55% |
| Marshall Wace | 36K | $1.51M | -91% |
| Blackstone | 8K | $342.6K | NEW |
13F holdings as of Jun 30, 2026
Explore all tracked funds →What are GRDN's key statistics?
Key statistics as of Nov 3, 2026
How does GRDN's valuation compare with the Healthcare sector?
| Metric | GRDN | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 39.1 | 29.7 | 114 |
| Net margin | 4.50% | 3.62% | 174 |
| Return on equity | 30.80% | 2.96% | 200 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 10, 2026). P/E excludes loss-making companies.
GRDN price chart
Powered by TradingViewWhat does Guardian Pharmacy Services, Inc. do?
Guardian Pharmacy Services Inc. is a company that provides comprehensive pharmacy services primarily focused on the long-term care and senior living sectors. Its primary function is to ensure the safe, efficient, and timely delivery of medications to residents in assisted living facilities, nursing homes, and other similar communities. Notable features of Guardian Pharmacy Services include personalized care plans, innovative pharmacy technology solutions, and a strong emphasis on regulatory compliance and medication safety. The company employs a collaborative approach, working closely with caregivers, healthcare professionals, and facility administrators to optimize pharmaceutical care outcomes. Guardian's services significantly impact the health management sector, contributing to improved quality of life for residents through tailored medication management systems. With a growing network of independent local pharmacies across the U.S., Guardian Pharmacy Services plays a vital role in the healthcare industry, addressing the unique needs of its clientele through specialization and dedicated service provision. The company's efforts in enhancing operational efficiencies and adopting advanced pharmacy practices underscore its market significance in delivering indispensable healthcare support.